Abiopharma

New Form 8-K - TherapeuticsMD, Inc. Filed: 2025-08-12 AccNo: 0001213900-25-074975 Size: 234 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Vicarious Surgical Inc. Filed: 2025-08-12 AccNo: 0001213900-25-074974 Size: 317 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 144 - ANI PHARMACEUTICALS INC Filed: 2025-08-12 AccNo: 0001950047-25-005665 Size: 4 KB

New Form 4 - BRUKER CORP Filed: 2025-08-12 AccNo: 0001415889-25-021491 Size: 8 KB

New Form 4 - BRUKER CORP Filed: 2025-08-12 AccNo: 0001415889-25-021492 Size: 12 KB

New Form 3 - 180 Life Sciences Corp. Filed: 2025-08-12 AccNo: 0001213900-25-074969 Size: 3 KB

New Form 4 - BRUKER CORP Filed: 2025-08-12 AccNo: 0001415889-25-021490 Size: 8 KB

New Form 4 - CARDINAL HEALTH INC Filed: 2025-08-12 AccNo: 0000721371-25-000084 Size: 4 KB

Vicarious Surgical Inc. - Vicarious Surgical Reports Second Quarter 2025 Financial Results

New Form 4 - ENSIGN GROUP, INC Filed: 2025-08-12 AccNo: 0001125376-25-000151 Size: 9 KB

Vicarious Surgical Reports Second Quarter 2025 Financial Results

vTv Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

New Form 4 - CARDINAL HEALTH INC Filed: 2025-08-12 AccNo: 0000721371-25-000083 Size: 4 KB

New Form 10-Q - Lyell Immunopharma, Inc. Filed: 2025-08-12 AccNo: 0001806952-25-000008 Size: 10 MB

New Form 8-K - Theravance Biopharma, Inc. Filed: 2025-08-12 AccNo: 0001104659-25-076837 Size: 5 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits